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Overweight, obesity, and breast cancer screening: results
from the 2012 Swiss Health Survey
Monika Eichholzera, Aline Richarda, Sabine Rohrmanna, Seraina Schmidb,c
and Uwe Güthd,e
Obesity is associated with poor breast cancer (BC)
prognosis. Larger tumor size and more advanced disease
stage at diagnosis could partly explain this outcome and
nonadherence of obese women to BC screening may play a
role. We examined the relationship between BMI (kg/m2)
and the use of mammography in Switzerland as well as
separately in the German-speaking part with mainly
opportunistic screening and in the French-speaking part
with organized programs. We analyzed the data of
50–69-year-old women (n= 3121) of the Swiss Health
Survey 2012. Study participants were classified as
underweight (BMI< 18.5), normal weight (BMI 18.5–24.9),
overweight (BMI 25–29), or obese (BMI≥ 30). Outcome
measures were dichotomized into 2 years or less since
most recent mammography versus more than 2 years or
never. We carried out multivariable logistic regression
analyses, adjusting for sociodemographics, lifestyle, and
self-perceived health. In Switzerland, 47% of women aged
50–69 years had had BC screening within the last 2 years,
35% of women in the German-speaking and 78% of women
in the French-speaking part. In the total group,
mammography use was higher in overweight than in
normal-weight women (adjusted odds ratio 1.21, 95%
confidence interval 0.98–1.49). Stratified by region, this
effect was only maintained in women of the German-
speaking part (adjusted odds ratio 1.41, 95% confidence
interval 1.08–1.85; P-interaction< 0.001). There were no
differences in mammography attendance between normal-
weight and obese and underweight women. In the 2012
Swiss Health Survey, overweight, obesity, and underweight
were no barriers to mammography. In the German-speaking
part, overweight women even attended mammography
screening more often than normal-weight women. European
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Introduction
Breast cancer (BC) is the most common cancer in women
in Switzerland. In most epidemiological studies, over-
weight and obesity were associated with a modest increase
in the risk of postmenopausal BC (Maruthur et al., 2009).
The increased risk of postmenopausal BC is considered to
be because of increased levels of estrogen in overweight
and obese women. After menopause, when the ovaries stop
producing hormones, fat tissue becomes the most impor-
tant source of estrogen. Because overweight and obese
women have more fat tissue, their estrogen levels are
higher, potentially leading to more rapid growth of
estrogen-responsive breast tumors (Pischon et al., 2008). In
addition, adult weight gain has been associated with an
increased risk of postmenopausal BC, and adjustment for
body weight at younger age did not modify this association
(Lahmann et al., 2005). Central obesity has also been found
to be associated positively with the risk of postmenopausal
BC, but the association between a smaller waist cir-
cumference or waist-hip-ratio and a lower risk of post-
menopausal BC seems to result from the associated
correlation with BMI, that is, adjustment for overall obesity
attenuated this relationship considerably (Harvie et al.,
2003).
In addition, being overweight or obese has been shown to
influence BC mortality and disease-free survival adversely
(Cohen et al., 2008; Parekh et al., 2012). Early detection of a
tumor with better prognosis may be impaired in large breasts
of obese women. It has been suggested that larger tumor
size, more advanced disease stage, and grade of the tumor at
diagnosis partly explain the observed poor outcome
(Carmichael and Bates, 2004; Majed et al., 2008; Deglise
et al., 2010). The findings of several, but not all, studies are in
accordance with this hypothesis (Moorman et al., 2001; Loi
et al., 2005; Chagpar et al., 2007). Nonadherence to BC
screening could be a possible explanation for these findings.
Are obese women less likely to follow recommendations for
BC screening? Meta-analyses of US-based studies observed
that morbidly obese (BMI≥40 kg/m2) white women older
than 40 years of age were significantly less likely to report
having had a mammography within the past 2 years
(Maruthur et al., 2009). Personal embarrassment may be an
explanation for the lower attendance at BC screening
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(Cohen et al., 2008). Studies including black women
(Maruthur et al., 2009) and various European surveys
(Peytremann-Bridevaux and Santos-Eggimann, 2007; Tekkel
et al., 2011; Beeken et al., 2014) did not show a decreased BC
screening adherence of overweight and obese women; in
some studies, even an increased BC screening attendance
was observed in overweight and obese women (Berz et al.,
2009; Tekkel et al., 2011; Beckmann et al., 2013). The sus-
pected association between obesity and nonattendance at
screening may be confounded by socioeconomic, lifestyle,
insurance status, and other factors (Bulliard et al., 2004;
Peytremann-Bridevaux and Santos-Eggimann, 2007; Walsh
et al., 2011; Vander Weg et al., 2012; Beckmann et al., 2013).
Remarkably, socioeconomic status was associated with parti-
cipation in opportunistic (individual) mammography screen-
ing, but not with the participation in population-based
programs (Palència et al., 2010; Walsh et al., 2011). Thus, it is
worthwhile to analyze adherence tomammography separately
for opportunistic and organized population-based BC
screening programs.
In addition, based on a Swiss prospective BC database of
the canton of Basle city, we had observed a positive
association between BMI and tumor size, disease stage,
and grading (Eichholzer et al., 2013). However, we were
not able to comment on the question of whether obesity
might be a barrier to BC screening because we had no
information on the general use of mammography
screening. Therefore, the aim of the present study was to
evaluate the use of BC screening among overweight,
obese, and underweight women compared with those
with normal body weight in Switzerland overall as well as
in the German-speaking part, with mainly opportunistic
screening, and in the French-speaking part, with orga-
nized programs. The analyses were based on results of
the Swiss Health Survey (SHS) 2012, and were restricted
to 50–69-year-old women, the main target group for BC
screening in Switzerland (Bulliard et al., 2011).
Methods
Study population and design
The current analysis used data of the cross-sectional 2012
SHS conducted by the Federal Office of Statistics (legal
basis: Ordinance of the Conduct of Federal Statistical
Surveys of 30 June 1993). This survey has been carried out
every 5 years since 1992. It provides important information
on the health status of the population, health behavior, and
the utilization of health services. Because of its regular
implementation, developments can be observed over time.
The data also serve as a basis to plan and evaluate health
policy strategies and preventive measures in Switzerland
(http://www.sgb12.bfs.admin.ch/). This survey comprised
participants selected randomly to represent the Swiss per-
manent population, that is, Swiss men and women and
foreigners with a legal work permit aged 15 years and older,
living in a private household based on registries of inha-
bitants. Of a sample of 41 008 individuals, a total of 21 597
agreed to participate in the survey (participation rate 54%).
Individuals aged 15–74 years were interviewed by tele-
phone. Furthermore, all participants were invited to com-
plete a written questionnaire. Only German-speaking,
French-speaking, or Italian-speaking individuals were
included in the survey.
A total of 11 314 women participated in the SHS 2012. Of
these, 3614 women were 50–69 years old. After excluding
women with missing information on BC screening
(n= 469) and women with no information on BMI
(n= 24), our final dataset consisted of 3121 participants.
Measurements
The outcome measure was the dichotomized mammo-
graphy status (≤ 2 years since most recent mammography
vs. > 2 years or never) on the basis of telephone
interview data.
The main independent variable of interest was BMI.
From self-reported body weight and height, BMI (kg/m2)
was calculated and divided into the following categories
(NIH, 1998): underweight (BMI< 18.5 kg/m2), normal
weight (BMI 18.5–24.9 kg/m2), overweight (BMI
25–29.9 kg/m2), and obesity (BMI≥ 30 kg/m2). Potential
confounding variables included sociodemographics (age,
marital status, education, area of residence, nationality),
health behaviors (smoking status, alcohol consumption,
physical activity), and self-perceived health. In the SHS,
the entire study sample comprised the German-speaking,
French-speaking, and Italian-speaking parts of
Switzerland, the language regions being defined by the
language of the municipality of the study participants’
residence.
Statistical analyses
For valid conclusions on the Swiss population on the
basis of the sample chosen, a comparison was made by
the Swiss Federal Office of Statistics with the permanent
2012 Swiss population with respect to sex, age, geo-
graphic region, and nationality (Swiss/non-Swiss); any
differences caused by stratification or nonparticipation
were corrected mathematically. The corresponding sam-
pling weights of the telephone interviews provided by
the Federal Office of Statistics were applied for the
present analyses and were used to calculate descriptive
characteristics (%) and to carry out logistic regression
analyses. All calculations and analyses were carried out
using STATA/SE, version 13 (StataCorp, College
Station, Texas, USA).
In our analyses, we used two logistic regression models.
Model 1 was unadjusted and model 2 was adjusted for
age (continuous), socioeconomic variables including
marital status (married, registered partnership vs. single,
widowed, divorced, separated, dissolved partnership),
educational level (low : compulsory education or less,
middle: secondary education, high : tertiary education),
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area of residence (urban, rural), nationality (Swiss, non-
Swiss), smoking status (current smoker, former smoker or
persons who have never smoked), chronic alcohol con-
sumption associated with a health risk (≥20 g ethanol daily
vs. less), physical activity (≥150min/week vs. less)
(Bundesamt für Sport BASPOBfGB, Gesundheitsförderung,
Schweiz bBfU, Suva, Netzwerk, Schweiz GuB, 2013), and
self-perceived health status (fair, poor, very poor vs. very
good, good).
In addition, we evaluated potential differences of attendance
at opportunistic BC screening or population-based programs
depending on BMI categories. In 2010, the entire French-
speaking part of Switzerland (with the exception of one
canton) was covered by an organized BC screening program.
The German-speaking part of Switzerland, in contrast, star-
ted introducing organized screening programs in 2010 and
later in some, but not all, cantons. Thus, at the time when
the 2012 SHS was carried out, in the German-speaking part
of Switzerland, mainly opportunistic BC screening existed
(http://www.brust-screening.ch). In Switzerland, all residents are
obliged by law (http://www.bag.admin.ch/themen/krankenversi
cherung/04114/04123/index.html?lang= en) to have health
insurance, but BC screening as a preventive measure is only
reimbursed for women aged 50 years and older every second
year if the mammography is part of a screening program with
predefined quality standards. Thus, in the German region of
Switzerland, women have to pay for preventive BC screen-
ing, whereas in the French region, women have to pay only a
small amount of money (https://assets.krebsliga.ch/downloads/
1408.pdf). Tests for interaction were performed using the
cross-product terms of the BMI categories and the dichot-
omized region of Switzerland (German vs. French). If the
confidence intervals (CIs) of the odds ratios (ORs) did not
include the value of 1.00, it was assumed that the findings
were statistically significant.
Results
Table 1 summarizes the sociodemographic characteristics
and lifestyle factors of the 3121 eligible women participating
in the 2012 SHS, and of women of the French and German
regions separately; 69.3% were living in the German-
speaking part of Switzerland, 25.6% in the French-
speaking region, and 5.1% in the Italian-speaking region.
In terms of educational status, 16.3% of the women had a
low level of education, 63.0% a middle level of education,
and 20.7% had a high level of education. In the German-
speaking part, a higher percentage of women with a middle
level of education were observed, 73.2% were living in a city
and 26.8% were living in a rural area, 87.6% were Swiss and
12.7% were of other nationalities (German-speaking and
French-speaking part: 10.5 and 16.4%). The majority of
women were married/living in a partnership (64.2%), the
percentage being lower in the French-speaking than in the
German-speaking part (59.3 and 66.0%). With respect to
BMI, 3.8% were underweight (BMI<18.5 kg/m2), 55.9%
were of normal weight (BMI 18.5–24.9 kg/m2), 27.4% were
overweight (BMI 25–29.9 kg/m2), and 12.8% were obese
(BMI≥30 kg/m2). Nearly half of the women had never
smoked (49.3%), 26.4% were former smokers, and 24.3%
were current smokers. Chronic daily alcohol consumption
was observed in 4.9% of women. Recommendations for
physical activity were not reached by 29.4% of the women,
and by 24 and 40.3% of the German-speaking and French-
speaking women. Self-perceived health was fair, poor, or
very poor for 22.8% of the participants; for 77.2% of the
women, it was good or very good (71.3% in the French
region and 80.0% in the German region).
In our study group, 22.1% of the women had never had a
BC screening examination, 46.9% had had one within the
past 2 years, and 30.9% had had mammography more
than 2 years ago (Table 1). In the German-speaking part
of Switzerland, with mainly opportunistic BC screening,
only 34.8% of women aged 50–69 years had had
Table 1 Baseline characteristicsa of 50–69-year-old women of the
2012 Swiss Health Survey
Total Switzerland
(%)
German
region (%)
French
region (%)
Women (nb) 3121 2006 869
Women 100.0 69.3 25.6
Mammography
Never 22.1 28.3 7.3
Within the last 2 years 46.9 34.8 78.3
More than 2 years ago 30.9 36.9 14.5
Educational level
Low 16.3 14.9 19.3
Middle 63.0 66.0 56.1
High 20.7 19.1 24.6
Area of residence
Urban 73.2 71.6 74.5
Rural 26.8 28.4 25.5
Nationality
Swiss 87.6 89.5 83.6
Non-Swiss 12.4 10.5 16.4
Marital status
Single, divorced/dissolved
partnership, separated,
widowed
35.8 34.0 40.7
Married/registered
partnership
64.2 66.0 59.3
BMIc
Underweight 3.8 3.6 3.8
Normal weight 55.9 55.2 57.8
Overweight 27.4 27.5 27.9
Obesity 12.8 13.8 10.5
Smoking status
Never smokers 49.3 51.0 45.0
Exsmokers 26.4 25.4 29.9
Current smokers 24.3 23.6 25.1
Alcohol≥20 g/day
Yes 4.9 3.9 6.7
No 95.1 96.1 93.3
Physical activity
<150min/week 29.4 24.1 40.3
≥150min/week 70.6 75.9 59.7
Self-perceived health
Fair, poor, very poor 22.8 20.0 28.7
Good, very good 77.2 80.0 71.3
aAll proportions are weighted, except n.
bn missing: education=17, marital status=2, alcohol=6, physical activity=11,
self-perceived health=8.
cUnderweight BMI<18.5 kg/m2; normal weight BMI 18.5–24.9 kg/m2; over-
weight BMI 25–29.9 kg/m2; obesity BMI≥30 kg/m2.
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mammography within the past 2 years, but 78.3% in the
French-speaking part, with free BC screening programs,
had had mammography.
Table 2 shows the associations between overweight,
obesity, and underweight and BC screening within the
past 2 years compared with mammography more than
2 years ago or never in the 2012 SHS. The adherence to
BC screening in the overall group of women was higher
in overweight women than in women with normal body
weight in the unadjusted model (OR 1.28, 95% CI
1.04–1.57). After adjustment for potential confounders
(i.e. age, educational level, area of residence, nationality,
marital status, smoking status, physical activity, alcohol
consumption, and self-perceived health), the positive
association did not remain statistically significant (OR
1.21, 95% CI 0.98–1.49). With respect to obese women,
we found a slightly higher adherence to BC screening
compared with normal-weight women, but crude (OR
1.18, 95% CI 0.90–1.55) and adjusted results (OR 1.01,
95% CI 0.75–1.35) were not statistically significant.
Table 2 presents, in addition, BC screening rates according to
BMI in the German-speaking and French-speaking parts of
Switzerland. Data were too limited to evaluate mammography
rates in the Italian-speaking part of Switzerland. Overweight
women from the German-speaking part of Switzerland had a
significantly higher attendance at BC screening than normal-
weight women (adjusted OR 1.41, 95% CI 1.08–1.85); for
obese women, the results were not statistically significant
(adjusted OR 1.32, 95% CI 0.92–1.88). In the French-
speaking region, attendance at BC screening did not differ
significantly between overweight, obese, and normal-weight
women (P-interaction<0.001). Comparison of adherence to
BC screening in women with a BMI of 25 and higher (i.e. the
total of overweight and obese women) with normal-weight
women resulted in similar findings, that is, a higher adherence
was only observed in the German-speaking, but not in the
French-speaking, part of Switzerland. Furthermore, under-
weight women did not differ from normal-weight womenwith
respect to attendance at BC screening in both regions.
Discussion
Our findings of the 2012 SHS suggest that overweight and
obesity do not represent obstacles to BC screening in
50–69-year-old women living in Switzerland. We observed
an even higher attendance rate at BC screening in over-
weight women. This finding was limited to women living
in the German-speaking part of Switzerland with mainly
opportunistic screening strategies. In the French-speaking
part with organized systematic BC screening programs, no
association was observed between BMI and attendance to
screening. The slightly higher adherence of obese women
to mammography was not statistically significant, and nei-
ther were the results in underweight women.
Our results do not confirm the findings of some previous
studies, for example from the USA, Korea, and Spain, Ta
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showing that obese women were less likely to follow
recommendations for BC screening than normal-weight
women (Cohen et al., 2008; Maruthur et al., 2009; Park
et al., 2012; Martín-López et al., 2013). Accordingly, in a
meta-analysis published in 2009, including studies car-
ried out in the USA (Maruthur et al., 2009), a significant
overall inverse relationship was found between class III
obesity (BMI≥40 kg/m2) and recent mammography. In
white women, a significant negative association with class
II (BMI 30–34.9 kg/m2) and class III obesity was
observed. As Cohen et al. (2008) pointed out, few studies
have investigated the reasons why overweight and obese
women have a lower attendance at BC screening. For
these authors, some reasons may not be weight related
(e.g. discomfort, being unaware of the importance of
screening, not having any health problems). Other rea-
sons may be weight specific, such as fear of receiving
unwanted weight-loss counsel from medical doctors and
personal embarrassment.
Our results are also not in agreement with the results of
surveys showing no associations between BC screening
attendance and overweight or obesity. Accordingly, in
African–American women, for example, obesity did not
negatively influence BC screening adherence. Women of
different ethnicities seem to perceive their weight differ-
ently (Caldwell et al., 1997; Flynn and Fitzgibbon, 1998;
Fitzgibbon et al., 2000; Anderson et al., 2002; Park et al.,
2012), and this may influence the willingness to undergo
mammography (Wee et al., 2004). In addition, in the 10
European countries participating in the Survey of Health,
Ageing and Retirement in Europe (SHARE), overweight
and obesity did not represent a barrier to mammography
use (Peytremann-Bridevaux and Santos-Eggimann, 2007).
The results of a more recent study from the UK (Beeken
et al., 2014) are in agreement with the SHARE findings.
The nonexistence of lower BC screening rates among over-
weight and obese compared with women with normal body
weight living in Switzerland and other European countries in
contrast to the USAmay be because of a higher percentage of
moderately and severely obese women in the USA than in
Europe (Peytremann-Bridevaux and Santos-Eggimann, 2007).
In our study group of women aged 50–69 years, no more than
1.3% (data not shown) had a BMI of 40 and higher, whereas
the prevalence in the USA was 9.8% in women aged
40–59 years in NHANES 2011/12 (Ogden et al., 2014). Thus,
our severely obese group might have been too small to detect
an association with mammography, especially as barriers to
mammography seem to increase with increasing BMI.
In our study, overweight and obesity not only repre-
sented no barrier to BC screening use, in overweight
women living in the German part of Switzerland, mam-
mography adherence was even significantly higher than
that in normal-weight women. Similarly, an increased BC
screening attendance was observed for overweight and
obese women in a study carried out in South Australia
(Beckmann et al., 2013), for overweight women in the
2004 US Behavioral Risk Factor Surveillance Survey
(BRFSS) from the USA (Berz et al., 2009), and for over-
weight women in an Estonian study (Tekkel et al., 2011).
According to Beckmann et al. (2013), normal-weight
women with smaller breasts might be more confident in
finding breast irregularities through self-examination and
might therefore consider the necessity to attend mam-
mography screening as less compelling.
In the present study, the higher BC screening adherence
of overweight than normal-weight women was only
observed for women living in the German-speaking part
of Switzerland with mainly nonopportunistic screening
strategies. According to Walsh et al. (2011), in opportu-
nistic programs, the burden of arranging mammography
falls on the individual. In addition, opportunistic pro-
grams may be more likely to have financial barriers
associated with them (in that individuals may be more
likely to pay for access) than population-based programs
(Walsh et al., 2011). In Switzerland, women of lower
social classes are more often affected by overweight than
women belonging to the highest social class (Eichholzer
et al., 2010). Thus, payment cannot be the argument for
the higher screening attendance of overweight women in
opportunistic programs. The higher attendance of mam-
mography in overweight women from Estonia was only
observed in those who received a written invitation and
not for opportunistic screening (Tekkel et al., 2011).
Similar results were observed in the survey from Australia
(Beckmann et al., 2013).
The association between overweight, obesity, and
attendance for BC screening may be confounded by
various factors. Previous studies generally showed that
marital status, social class, tobacco smoking, alcohol
drinking, health insurance status, general health percep-
tion, region of residence, physical activity, and nationality
were associated with adherence to mammography
screening (Galán et al., 2006; Peytremann-Bridevaux and
Santos-Eggimann, 2007; Berz et al., 2009; Simou et al.,
2010; Vander Weg et al., 2012; Martín-López et al., 2013).
Even though we adjusted for all these factors (with the
exception of health insurance) in our study, residual
confounding could still be a potential explanation for our
unexpected results, which should be further investigated.
Study strengths and limitations
The strengths of our study included the large database of
a representative sample of noninstitutionalized indivi-
duals 15 years and older living in Switzerland, allowing
limitation of our analyses to women aged 50–69 years. We
did not merge underweight with the normal-weight
women because adherence to BC screening might dif-
fer between these groups (Fontaine et al., 2001; Berz
et al., 2009). Nevertheless, the main aim of the present
study was to evaluate the association of overweight and
obesity with adherence to BC screening.
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This study also has several limitations. It is a cross-
sectional survey; thus, causality cannot be inferred. In
addition, data were self-reported. This could result in
reporting and/or recall biases. Selection bias cannot be
excluded because, in the SHS, participants were selected
from the resident population in private households,
excluding individuals living in homes for the elderly, or
other similar institutions or collective households. In
addition, 46% of eligible participants did not participate
(32% were not attainable despite repeated attempts to
reach them, 13% refused because of lack of interest and/
or lack of time, etc.). The use of weighting factors
nevertheless allowed for the extrapolation of the results
in relation to age, sex, region, and nationality from the
sample to the total population living in Switzerland
(http://www.sgb12.bfs.admin.ch/). Extrapolation of results of
other subgroups could be impaired because of the miss-
ing values for nonparticipants. It is for example known
that nonparticipants of health surveys tend to belong to
lower socioeconomic and less health conscious groups
compared with participants. This could lead to under-
estimation and overestimation of the associations
observed (Delgado-Rodriguez and Llorca, 2004).
In terms of mammography use, women seem to over-
estimate their adherence to cancer screening and to
report it as occurring more recently then it actually did
(Rauscher et al., 2008; Howard et al., 2009). For self-
reported weight and height in most, but not all, studies,
individuals overestimated their height and under-
estimated their weight. This was particularly true for
obese women. BMI therefore tends to be underestimated
(Connor Gorber et al., 2007; Peytremann-Bridevaux and
Santos-Eggimann, 2007; Faeh et al., 2008). Thus, the
actual percentage of overweight and obese women in the
present study is most probably higher than our estimates.
Another limitation is the lack of information in the 2012
SHS on why women did not follow BC screening
recommendations.
Conclusion
The results of the 2012 SHS indicate that overweight and
obese women do not attend mammography screening less
often than normal-weight women. In the German-speaking
part of Switzerland, with mainly opportunistic screening,
even the opposite is true for overweight women. In the
French-speaking region, with organized BC screening
programs, the screening attendance did not differ sig-
nificantly between overweight, obese, and normal-weight
women. Thus, for Switzerland, high body weight does not
seem to be a barrier to mammography use.
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